ARM's stock has tripled since January, driven by strong demand for its AI silicon and growing data-center royalties. The company is transitioning from licensing to producing its own AI chips, with significant customer demand expected through 2028. However, ARM trades at very high valuation multiples, with recent GAAP earnings misses and margin pressures raising concerns. Risks include a pending Qualcomm trial and China export controls. Investors are advised to watch upcoming earnings and AGI CPU production ramp before committing, as the current price reflects high expectations that may not leave room for error.
As of Sep 18, 2026 18:51 WIB, ARM trades at USD 268.39, up 1.32% for the day on Pluang. This price sits well below its 52-week high of USD 439.46 but far above its 52-week low of USD 104.55, reflecting significant volatility within the year. Despite the recent gains, Pluang order activity shows a slight tilt toward selling at 53%, indicating mixed investor sentiment amid the high valuation and upcoming risks discussed in the news.
Arm's CEO Rene Haas reports unprecedented demand across multiple sectors like edge, automotive, robotics, and data centers, with order books overflowing. However, the company struggles to meet targets due to a multi-stage supply chain bottleneck invo...
Arm is positioned as a key player in the AI infrastructure boom, benefiting from growing royalty revenues tied to hyperscaler CPU programs. The stock trades at $264.79 with a 24/7 Wall St. price target of $280.16, suggesting a moderate 5.8% upside ov...
